“…Currently, multiple combinations of various therapeutic and diagnostic modalities are adopted to achieve a theranostic effect (Orecchioni et al, 2015; Ji et al, 2019), and can be further improved and expanded thanks to the development of NM-based theranostic nanoplatforms. Among 2D NMs suitable for this purpose, graphene and graphene-based materials (GBMs), including few layer graphene (FLG), graphene oxide (GO), reduced graphene oxide (rGO), nano-graphene oxide (NGO), and graphene quantum dots (GQDs), bring the technological innovations needed to the current societal and industrial challenges (Boukhvalov and Katsnelson, 2008; Park and Ruoff, 2009; Gao et al, 2010; Kuila et al, 2012; Mao et al, 2012; James and Tour, 2013; Quintana et al, 2013; Yang et al, 2013a; Roppolo et al, 2014; Sechi et al, 2014; Servant et al, 2014; Kim et al, 2016; Shin et al, 2016; McManus et al, 2017; Park et al, 2017).…”